18FDG PET/CT:

ISBN-13: 9786204642192 / Angielski / Miękka / 92 str.

Dorra Ben Sellem; Nesrine Zouari; Naima Ben Rejeb

Opis

Positron emission tomography coupled with 2-deoxy-2-18F-fluoro-D-glucose computed tomography (18FDG PET/CT) has become established at various stages of cancer management. The aim of this prospective study, including 60 patients, was to evaluate the contribution of 18FDG PET/CT in an oncologic population that had benefited from this examination. The mean age was 39 years, with a sex ratio of 0.7. The 18FDG PET/CT scan was performed as part of an initial extension workup (13%), early mid-treatment evaluation (5%), end-of-treatment evaluation (49%), recurrence search and workup (29%), and search for iodine-refractory differentiated thyroid cancer lesions (5%). PET had a positive impact in 80% of cases. It helped guide the therapist in his management by adapting the treatment in 28 cases, continuing the same treatment in nine cases, stopping the treatment in 10 cases and continuing the monitoring in one case. These results confirm the importance of 18FDG PET/CT in the management of cancer pathologies at their different stages.

O autorze

Ben Sellem, DorraDorra BEN SELLEM is a university hospital professor in Biophysics and Nuclear Medicine, MD, PhD, Tunis El Manar University, Faculty of Medicine of Tunis. Nesrine ZOUARI holds a master's degree in research from ISTMT. Naima BEN REJEB is a PhD student at the ISTMT Biophysics and Medical Technologies research laboratory.